SEC Form 25-NSE filed by cbdMD Inc.

5/6/25 9:38:10 AM ET

$YCBD

Package Goods/Cosmetics

Consumer Discretionary

Get the next $YCBD alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-38299

Issuer:	cbdMD, Inc.
Exchange:	NYSE AMERICAN LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	4521 Sharon Road
	Charlotte	NORTH CAROLINA	28211
Telephone number:				(704) 362-6291

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

8.0% Series A Cumulative Convertible Preferred Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NYSE AMERICAN LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-05-06	By	Emily Fuhrman		Senior Analyst, Regulation
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $YCBD alert in real time by email

SEC Form 25-NSE filed by cbdMD Inc.

5/6/25 9:38:10 AM ET

$YCBD

Package Goods/Cosmetics

Consumer Discretionary

Get the next $YCBD alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-38299

Issuer:	cbdMD, Inc.
Exchange:	NYSE AMERICAN LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	4521 Sharon Road
	Charlotte	NORTH CAROLINA	28211
Telephone number:				(704) 362-6291

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

8.0% Series A Cumulative Convertible Preferred Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

2025-05-06	By	Emily Fuhrman		Senior Analyst, Regulation
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $YCBD alert in real time by email

SEC Form 25-NSE filed by cbdMD Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$YCBD

SEC Form 25-NSE filed by cbdMD Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$YCBD

$YCBD
Press Releases

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum

cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways

$YCBD
Insider Trading

Large owner Crosnoe Clark R. sold $1,276,842 worth of shares (550,701 units at $2.32) (SEC Form 4)

CEO and CFO Kennedy Thomas Ronan was granted 445,000 shares, increasing direct ownership by 648% to 513,722 units (SEC Form 4)

Director Porter Jeffrey H was granted 1,572 shares (SEC Form 4)

$YCBD
Analyst Ratings

Cantor Fitzgerald resumed coverage on cbdMD with a new price target

Cantor Fitzgerald reiterated coverage on cbdMD with a new price target

$YCBD
SEC Filings

SEC Form PRE 14A filed by cbdMD Inc.

SEC Form S-1 filed by cbdMD Inc.

Amendment: SEC Form 10-K/A filed by cbdMD Inc.

$YCBD
Leadership Updates

cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega

cbdMD Welcomes Shannon Charles as Chief Marketing Officer

$YCBD
Financials

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2025, Fourth Quarter and Fiscal Year 2025 Results

$YCBD
Large Ownership Changes

SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

SEC Form 25-NSE filed by cbdMD Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $YCBD

SEC Form 25-NSE filed by cbdMD Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $YCBD

$YCBD Press Releases

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum

cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways

$YCBD Insider Trading

Large owner Crosnoe Clark R. sold $1,276,842 worth of shares (550,701 units at $2.32) (SEC Form 4)

CEO and CFO Kennedy Thomas Ronan was granted 445,000 shares, increasing direct ownership by 648% to 513,722 units (SEC Form 4)

Director Porter Jeffrey H was granted 1,572 shares (SEC Form 4)

$YCBD Analyst Ratings

Cantor Fitzgerald resumed coverage on cbdMD with a new price target

Cantor Fitzgerald reiterated coverage on cbdMD with a new price target

$YCBD SEC Filings

SEC Form PRE 14A filed by cbdMD Inc.

SEC Form S-1 filed by cbdMD Inc.

Amendment: SEC Form 10-K/A filed by cbdMD Inc.

$YCBD Leadership Updates

cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega

cbdMD Welcomes Shannon Charles as Chief Marketing Officer

$YCBD Financials

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results

cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2025, Fourth Quarter and Fiscal Year 2025 Results

$YCBD Large Ownership Changes

SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

Recent Analyst Ratings for
$YCBD

Recent Analyst Ratings for
$YCBD

$YCBD
Press Releases

$YCBD
Insider Trading

$YCBD
Analyst Ratings

$YCBD
SEC Filings

$YCBD
Leadership Updates

$YCBD
Financials

$YCBD
Large Ownership Changes